在未经选择的初发无诱因静脉血栓栓塞患者中，JAK2 V617F突变的发生率较低。 - Suppr

Suppr

超能文献

Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism.

作者信息

Ugo V, Le Gal G, Lecucq L, Mottier D, Oger E

出版信息

J Thromb Haemost. 2008 Jan;6(1):203-5. doi: 10.1111/j.1538-7836.2007.02811.x. Epub 2007 Oct 22.

DOI:10.1111/j.1538-7836.2007.02811.x

PMID:17949475

Abstract

摘要

相似文献

Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism.

J Thromb Haemost. 2008 Jan;6(1):203-5. doi: 10.1111/j.1538-7836.2007.02811.x. Epub 2007 Oct 22.

Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolism.

Br J Haematol. 2011 Nov;155(4):511-3. doi: 10.1111/j.1365-2141.2011.08701.x. Epub 2011 Apr 26.

Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms.

Br J Haematol. 2009 Mar;144(6):965-7. doi: 10.1111/j.1365-2141.2008.07537.x. Epub 2008 Dec 11.

The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.

Thromb Res. 2015 Feb;135(2):272-80. doi: 10.1016/j.thromres.2014.11.006. Epub 2014 Nov 15.

The JAK2 V617F mutational status and allele burden.

Thromb Res. 2015 Sep;136(3):690. doi: 10.1016/j.thromres.2015.07.008. Epub 2015 Jul 13.

The JAK2 V617F mutational status and allele burden--authors' reply.

Thromb Res. 2015 Sep;136(3):691-2. doi: 10.1016/j.thromres.2015.07.006. Epub 2015 Jul 10.

Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.

Thromb Haemost. 2008 Mar;99(3):640-2. doi: 10.1160/TH07-09-0570.

Is the JAK2 V617F mutation a hallmark for different forms of thrombosis?

Acta Haematol. 2010;124(1):49-56. doi: 10.1159/000314645. Epub 2010 Jul 9.

JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort.

Ann Hematol. 2017 Mar;96(3):383-386. doi: 10.1007/s00277-016-2853-1. Epub 2016 Oct 20.

Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.

Chest. 2009 Dec;136(6):1537-1545. doi: 10.1378/chest.09-0757. Epub 2009 Jul 10.

引用本文的文献

CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease.

Blood Adv. 2025 Jan 28;9(2):343-353. doi: 10.1182/bloodadvances.2024014430.

Clinical epidemiology of venous thromboembolic disease: An institutional registry.

Front Cardiovasc Med. 2022 Jul 22;9:928094. doi: 10.3389/fcvm.2022.928094. eCollection 2022.

JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature.

Thromb J. 2021 Mar 10;19(1):16. doi: 10.1186/s12959-021-00269-8.

Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders.

Maedica (Bucur). 2015 Mar;10(1):27-32.

Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?

Blood Cancer J. 2012 May;2(5):e70. doi: 10.1038/bcj.2012.15. Epub 2012 May 4.

Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg.

Ann Hematol. 2012 Jan;91(1):103-7. doi: 10.1007/s00277-011-1233-0. Epub 2011 Apr 12.

Polycythemia vera.

Intern Emerg Med. 2010 Oct;5(5):375-84. doi: 10.1007/s11739-010-0369-6. Epub 2010 Mar 16.

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

Haematologica. 2009 Jan;94(1):38-45. doi: 10.3324/haematol.13486. Epub 2008 Nov 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验